← Back to Search

Procedure

VenaSeal for Varicose Veins (New-WAVES Trial)

N/A
Waitlist Available
Led By Kathleen Gibson, MD
Research Sponsored by Lake Washington Vascular
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years post treatment
Awards & highlights

Summary

New-WAVES Study seeks to expand understanding/results from prior study (NCT02585726). Assessing both clinical outcomes and patient satisfaction after treatment with Venaseal/Cyanoacrylate Adhesive Closure System

Eligible Conditions
  • Venous Reflux Disease
  • Varicose Veins

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Complete Closure of Target Vein(s) at 3 years after index treatment
Secondary study objectives
Clinical Severity via Varicose Vein Questionnaire (AVVQ)
Health care utilization
Need for adjunctive treatments
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: VenaSealExperimental Treatment1 Intervention
Complete closure of previously treated veins will be assessed via ultrasound
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~4090

Find a Location

Who is running the clinical trial?

Lake Washington VascularLead Sponsor
5 Previous Clinical Trials
757 Total Patients Enrolled
2 Trials studying Varicose Veins
567 Patients Enrolled for Varicose Veins
Medtronic VascularIndustry Sponsor
65 Previous Clinical Trials
56,138 Total Patients Enrolled
Kathleen Gibson, MDPrincipal InvestigatorLake Washington Vascular, PLLC
2 Previous Clinical Trials
671 Total Patients Enrolled
~21 spots leftby Sep 2025